Found 6 matching trials
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing PHASE2 Patients with salivary gland carcinoma were divided into groups according t...
Show More Learn More & Join Trial
Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast Cancer NA Phase II trial of Neoadjuvant \[FEC100\]/Cisplatin-Docetaxel ± Trastuzumab ...
Show More Location
Multiple Locations
Learn More & Join Trial
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) PHASE1 The purpose of this study will be to evaluate the safety, tolerability, and...
Show More Location
University of Alabama At Birmingham Comprehensive Cancer Center
Learn More & Join Trial
A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer PHASE1 This study is an open-label, dose-escalation study of MM-111 with five diff...
Show More Location
Rocky Mountain Cancer Centers
Learn More & Join Trial
PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer PHASE3 This study aims to explore new PERS prediction model can improve the pathol...
Show More Location
Sun Yat-sen University
Learn More & Join Trial
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma PHASE2 Chemotherapy given together is a standard way to treat your cancer. One sta...
Show More Location
City of Hope Cancer Center
Treatments Being Tested
Docetaxel, Leucovorin, Fluorouracil, Cisplatin Docetaxel, Cisplatin, Fluorouracil, Neulasta, or Neupogen Docetaxel, Leukvorin, Flurouracil, Cisplatin, Trastuzumab Learn More & Join Trial